View in EDS

Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes.

Saved in:
Bibliographic Details
Title: Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes.
Authors: Hammerslag LR; Institute for Biomedical Informatics, College of Medicine, University of Kentucky, United States of America; Department of Internal Medicine, College of Medicine, University of Kentucky, United States of America. Electronic address: l.hammerslag@uky.edu., Talbert J; Institute for Biomedical Informatics, College of Medicine, University of Kentucky, United States of America; Department of Internal Medicine, College of Medicine, University of Kentucky, United States of America., Slavova S; Department of Biostatistics, College of Public Health, University of Kentucky, United States of America., Lei F; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, United States of America., Freeman PR; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, United States of America., Marks KR; Department of Behavioral Science, College of Medicine, University of Kentucky, United States of America., Fanucchi LC; Department of Internal Medicine, College of Medicine, University of Kentucky, United States of America; Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, United States of America., Walsh SL; Department of Behavioral Science, College of Medicine, University of Kentucky, United States of America; Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, United States of America., Lofwall MR; Department of Behavioral Science, College of Medicine, University of Kentucky, United States of America; Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, United States of America.
Source: Journal of substance use and addiction treatment [J Subst Use Addict Treat] 2024 Sep; Vol. 164, pp. 209391. Date of Electronic Publication: 2024 May 11.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918541186406676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2949-8759 (Electronic) Linking ISSN: 29498759 NLM ISO Abbreviation: J Subst Use Addict Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2949-8759
DOI:10.1016/j.josat.2024.209391